TLR4 antagonist ameliorates combined allergic rhinitis and asthma syndrome (CARAS) by reducing inflammatory monocytes infiltration in mice model
Authors:
- 1 August 2019
- journal article
- research article
- Published by Elsevier in International Immunopharmacology
- Vol. 73, 254-260
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- MyD88-dependent and independent pathways of Toll-Like Receptors are engaged in biological activity of Triptolide in ligand-stimulated macrophagesBMC Chemical Biology, 2010
- Role played by Th2 type cytokines in IgE mediated allergy and asthmaLung India, 2010
- Monocyte Chemoattractant Protein-1 (MCP-1): An OverviewJournal of Interferon & Cytokine Research, 2009
- Allergic Rhinitis and asthma: are they manifestations of one syndrome?Clinical & Experimental Allergy, 2005
- The effectiveness of intranasal corticosteroids in combined allergic rhinitis and asthma syndromeClinical & Experimental Allergy, 2004
- A role for eosinophils in airway remodelling in asthmaTrends in Immunology, 2004
- Allergic rhinitisJournal of Allergy and Clinical Immunology, 2003
- Toll-like receptors: cellular signal transducers for exogenous molecular patterns causing immune responsesInternational Journal of Medical Microbiology, 2001
- Induction of natural killer cell migration by monocyte chemotactic protein−1, −2 and −3European Journal of Immunology, 1994
- T cells and eosinophils in the pathogenesis of asthmaImmunology Today, 1992